Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and Other variants of concern.

Name: Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and Other variants of concern.
Published: 2021-12-28T00:00:00+08:00

NCATS Open Data2021-12-31 更新2026-08-08 收录

抗新冠病毒药物活性

SARS-CoV-2变异株药敏研究

数据链接：

https://doi.org/10.1101/2021.12.27.474275 数据链接链接失效反馈

官方服务：

资源简介：

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and Other variants of concern.

创建时间：

2021-12-28

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and Other variants of concern.

资源简介：

相关数据集